Severe Bullous Hypersensitivity Reaction After Copperhead Snakebite and Antivenom Therapy

Main Article Content

Isha Jhingan, BS
University of Oklahoma College of Medicine

Charles F. Hojjat, BS
University of Oklahoma College of Medicine

Francesca L. Veon, DO
Department of Dermatology, University of Oklahoma College of Medicine

Amanda S. Weissman, MD
Department of Dermatology, University of Oklahoma College of Medicine

Jeffrey D. McBride, MD, PhD
Department of Dermatology, University of Oklahoma College of Medicine

Lindsey K. Collins, MD
Department of Dermatology, University of Oklahoma College of Medicine

Keywords

bullous reaction, hypersensitivity reaction, antivenom, snakebite, dermatology, immunology

References

1. Pallardy M, Bechara R, Whritenour J, et al. Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis. Toxicol Sci. 2024;200(1):11-30. doi:10.1093/toxsci/kfae046

2. de Silva HA, Ryan NM, de Silva HJ. Adverse reactions to snake antivenom, and their prevention and treatment. Br J Clin Pharmacol. 2016;81(3):446-452. doi:10.1111/bcp.12739

3. Shah KN, Honig PJ, Yan AC. "Urticaria multiforme": a case series and review of acute annular urticarial hypersensitivity syndromes in children. Pediatrics. 2007;119(5):e1177-e1183. doi:10.1542/peds.2006-1553

4. Creamer JD, McGrath JA, Webb-Peploe M, Smith NP. Serum sickness-like illness following streptokinase therapy. A case report. Clin Exp Dermatol. 1995;20(6):468-470. doi:10.1111/j.1365-2230.1995.tb01379.x

5. Li X, Qu LX, Ren YM, Hu C. Case Report: A Case Report and Literature Review on Severe Bullous Skin Reaction Induced by anti-PD-1 Immunotherapy in a Cervical Cancer Patient. Front Pharmacol. 2021;12:707967. doi:10.3389/fphar.2021.707967

Article Sidebar

PDF
Published
Mar 17, 2025
DOI https://doi.org/10.25251/skin.9.2.20

Article Details

How to Cite
[1]
Jhingan, I., Hojjat, C., Veon, F., Weissman, A., McBride, J. and Collins, L. 2025. Severe Bullous Hypersensitivity Reaction After Copperhead Snakebite and Antivenom Therapy. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), 2272–2274. DOI:https://doi.org/10.25251/skin.9.2.20.
Issue
Vol. 9 No. 2 (2025): March 2025 Issue
Section
SKINmages: Clinical Images in Dermatology
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.